Atrial Natriuretic Peptide Release during Volume Expansion in the Menstrual Cycle

1991 ◽  
Vol 80 (s24) ◽  
pp. 12P-12P
Author(s):  
D L Bisson ◽  
D. Hampson ◽  
M D Penney ◽  
G D Dunster ◽  
J P O'Hare
1995 ◽  
Vol 92 (17) ◽  
pp. 7902-7906 ◽  
Author(s):  
M. A. Haanwinckel ◽  
L. K. Elias ◽  
A. L. Favaretto ◽  
J. Gutkowska ◽  
S. M. McCann ◽  
...  

1990 ◽  
Vol 258 (3) ◽  
pp. R704-R710 ◽  
Author(s):  
Y. Shiraishi ◽  
S. Fujimura ◽  
M. Handa ◽  
T. Kimura ◽  
K. Ota ◽  
...  

To assess the effect of cardiopulmonary denervation on the release of arginine vasopressin (AVP) and atrial natriuretic peptide (ANP), either hemorrhage (1.0 ml.kg-1.min-1, for 40 min) or an infusion of 3% dextran in lactated Ringer solution (RL) (3% dextran in RL, 1.0 ml.kg-1.min-1, for 40 min) was carried out in chronic cardiopulmonary denervated (CPD, n = 7) and sham-operated (SO, n = 7) dogs under anesthesia. Plasma AVP increased significantly in both groups during hemorrhage, but its rise was significantly attenuated in CPD dogs. Plasma ANP decreased similarly during hemorrhage in both groups. An infusion of 3% dextran in RL decreased significantly plasma AVP during its whole period in SO dogs, but AVP release was only suppressed in the late period in SO dogs. Plasma ANP increased significantly during its infusion in both groups. These results indicate that cardiopulmonary denervation may attenuate the release of AVP in response to either hemorrhage or blood volume expansion but may not affect the release of ANP in response to the blood volume change. Moreover, a large increase in plasma ANP may attenuate the release of AVP.


Peptides ◽  
1987 ◽  
Vol 8 (2) ◽  
pp. 257-260 ◽  
Author(s):  
Yasuhiro Kabayama ◽  
Yuzou Fukamachi ◽  
Takeshi Kamisaki ◽  
Hiromitsu Tanaka

Diabetes ◽  
1990 ◽  
Vol 39 (3) ◽  
pp. 289-298 ◽  
Author(s):  
R. Trevisan ◽  
P. Fioretto ◽  
A. Semplicini ◽  
G. Opocher ◽  
F. Mantero ◽  
...  

1993 ◽  
Vol 11 (5) ◽  
pp. S218???S219 ◽  
Author(s):  
Jean-Pierre Valentin ◽  
Wei-Zhong Ying ◽  
Leonardo A. Sechi ◽  
Michael H. Humphreys

1993 ◽  
Vol 58 (6) ◽  
pp. 696-700 ◽  
Author(s):  
José Antunes-Rodrigues ◽  
Domingos W.L. Picanco-Diniz ◽  
Ana L.V. Favaretto ◽  
Jolanta Gutkowska ◽  
Samuel M. McCann

1991 ◽  
Vol 261 (5) ◽  
pp. H1353-H1357
Author(s):  
N. L. Wong ◽  
D. C. Hu ◽  
E. F. Wong

Magnesium is the second most abundant divalent ion in the body, but the effects of this cation on atrial natriuretic peptide (ANP) release have not been examined. The present study was conducted to determine the effect of magnesium on ANP secretion. Experiments were conducted in six groups of male Wistar rats. Each group was assigned a diet containing a different amount of magnesium. Plasma magnesium was 0.42 +/- 0.01, 0.63 +/- 0.01, 0.75 +/- 0.02, 0.97 +/- 0.03, 1.03 +/- 0.01, and 1.19 +/- 0.01 mM in groups I, II, III, IV, V, and VI, respectively. Plasma ANP concentration was significantly higher in the hypermagnesemic animals and significantly lower in the hypomagnesemic rats. A significant positive correlation was found between plasma magnesium and plasma ANP levels (y = 88 + 23 chi; r = 0.46; P less than 0.01). ANP concentration in the atria was lower in hypomagnesemic rats and higher in hypermagnesemic rats. This suggests that the low concentrations of ANP found in the plasma of hypomagnesemic animals were due to the lack of ANP in the atria. The atria from the various groups were isolated and perfused in a modified Langendorff apparatus to measure the rate of ANP secretion. Our results showed that the hypomagnesemic rats have a lower release rate as opposed to that seen in hypermagnesemic animals. A significant correlation was also seen between ANP secretion and tissue ANP concentration. The higher rate of ANP release from the heart of hypermagnesemic animals was due to the presence of more ANP, which was reduced during hypomagnesemia.(ABSTRACT TRUNCATED AT 250 WORDS)


Sign in / Sign up

Export Citation Format

Share Document